Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuropathy Demyelinating”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Post-approval studies (Phase 4)Enrolling By InvitationNCT02670161
What this trial is testing

Quality Improvement and Practice Based Research in Neurology Using the EMR

Who this might be right for
Brain TumorsEpilepsyMigraine+7 more
Endeavor Health 3,300
Not applicableLooking for participantsNCT06343558
What this trial is testing

Gait and Balance Impairment in Rare and Very Rare Neurological Diseases

Who this might be right for
Multiple SclerosisParkinson DiseasePeripheral Neuropathy+3 more
Istituto Auxologico Italiano 200
Early research (Phase 1)Looking for participantsNCT05584631
What this trial is testing

IVIG vs SCIG in CIDP

Who this might be right for
CIDPImmunoglobulin DeficiencyChronic Inflammatory Demyelinating Polyneuropathy
Rutgers, The State University of New Jersey 20
Large-scale testing (Phase 3)Study completedNCT00004939
What this trial is testing

Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy

Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
National Center for Research Resources (NCRR) 34
Early research (Phase 1)Ended earlyNCT03701711
What this trial is testing

Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study

Who this might be right for
Demyelinating Sensorimotor Neuropathy
Ohio State University 11
Large-scale testing (Phase 3)Ended earlyNCT02317562
What this trial is testing

Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302

Who this might be right for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Laboratoire français de Fractionnement et de Biotechnologies 19
Not applicableUnknownNCT01655394
What this trial is testing

Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

Who this might be right for
Guillain-Barre SyndromeCIDPMultifocal Motor Neuropathy
University of Cologne 50
Not applicableStudy completedNCT00906737
What this trial is testing

Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait Abnormalities

Who this might be right for
Multiple Sclerosis
Mount Sinai Rehabilitation Hospital 18
Not applicableUnknownNCT05940922
What this trial is testing

RWE-based Treatment Patterns and Outcomes in CIDP

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyGuillain-Barre SyndromeHereditary Amyloidosis
RwHealth 170
Not applicableEnded earlyNCT03886753
What this trial is testing

Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products

Who this might be right for
ALSAutism Spectrum DisorderCancer+15 more
Children's Hospital of Philadelphia 10
Testing effectiveness (Phase 2)Ended earlyNCT03536559
What this trial is testing

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisOptic NeuropathyOptic; Neuritis, With Demyelination
Clene Nanomedicine 73
Testing effectiveness (Phase 2)Study completedNCT00278629
What this trial is testing

Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Northwestern University 80
Large-scale testing (Phase 3)Looking for participantsNCT05327114
What this trial is testing

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Janssen Research & Development, LLC 201
Not applicableStudy completedNCT01977287
What this trial is testing

Walking With FES or AFO in People With MS With Foot Drop

Who this might be right for
Multiple SclerosisFoot Drop
Queen Margaret University 18
Post-approval studies (Phase 4)Looking for participantsNCT04589299
What this trial is testing

Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)

Who this might be right for
CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
University of Aarhus 60
Not applicableStudy completedNCT02123537
What this trial is testing

Treating Foot Drop in People With Multiple Sclerosis Using Electrical Stimulation

Who this might be right for
Multiple SclerosisFoot Drop
University of Manitoba 10
Testing effectiveness (Phase 2)Study completedNCT04281472
What this trial is testing

Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
argenx 322
Not applicableActive Not RecruitingNCT07597733
What this trial is testing

Telitacicept for Refractory Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
Refractory Chronic Inflammatory Demyelinating Polyneuropathy
Sichuan Academy of Medical Sciences 76
Testing effectiveness (Phase 2)WithdrawnNCT02574962
What this trial is testing

Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Mamatha Pasnoor, MD
Next Page